ClinicalTrials.Veeva

Menu

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Covid19
SARS-CoV-2
Rapid Antigen Test

Treatments

Diagnostic Test: Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.

Study type

Interventional

Funder types

Other

Identifiers

NCT04689399
COVID-19

Details and patient eligibility

About

This project aims to investigate the sensitivity and specificity of the rapid antigen test compared to RT-PCR test performed on samples from the nasopharynx and the anterior nasal cavity and the oropharynx, respectively.

Full description

The purpose of the study is to investigate the sensitivity and specificity of correct SARS-CoV-2 test results of nasopharyngeal swabs and swabs swabs from the anterior part of the nose examined by rapid antigen test (Standard Q COVID-19 Ag - test, SD Biosensor INC.) compared with swabs from the oropharynx examined by RT-PCR test among citizens who have booked an appointment for a COVID-19 test in one of Testcenter Denmark's test centers in the Capital Region.

Enrollment

4,697 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • A booked appointment for a COVID-19 test at one of Testcenter Denmark's test centers in the Capital Region

Exclusion criteria

  • Previously tested positive for COVID-19
  • Non-fluent in Danish

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems